Stay updated with breaking news from Simon Connal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares in Australian biopharmaceutical company Mesoblast jumped 25 per cent after Revascor was recognised as a potential treatment for heart disease in babies.
After another knockback from the US regulator, its sceptics say it’s business as usual. And Mesoblast chief executive Silviu Itescu remains as optimistic as ever.
A corporate governance advisor claims there's "sorcery" involved in Mike Cannon-Brookes' stake in AGL shares.
Willem Blijdorp, chairman of the ASX-listed biotech and one of the Netherlands’ wealthiest entrepreneurs, is accused of extortion and forgery relating to Iranian marble quarries.
Push to kneecap super proxy advisers Apr 30, 2021 – 9.30pm Share The influential advisory firm controlled by the $500 billion industry super fund sector would be kneecapped under a push by Treasurer Josh Frydenberg to regulate the way institutional shareholders vote on how companies deal with environmental, social and governance issues. The proposed measures include forcing proxy advisers to give the companies they are reviewing a week’s notice of how they are recommending shareholders should vote and the research on which it is based. Firms would also have to give clients access to the c...